These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37397463)

  • 1. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.
    Staben J; Koch M; Reid K; Muckerheide J; Gilman L; McGuinness F; Kiesser S; Oswald IWH; Koby KA; Martin TJ; Kaplan JS
    Front Neurosci; 2023; 17():1185737. PubMed ID: 37397463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism.
    Shrader SH; Mellen N; Cai J; Barnes GN; Song ZH
    Front Neurosci; 2024; 18():1359810. PubMed ID: 38784096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory.
    Kaplan JS; Wagner JK; Reid K; McGuinness F; Arvila S; Brooks M; Stevenson H; Jones J; Risch B; McGillis T; Budinich R; Gambell E; Predovich B
    Front Behav Neurosci; 2021; 15():711639. PubMed ID: 34512286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report.
    Raz N; Heller I; Lombardi T; Marino G; Davidson EM; Eyal AM
    Front Pharmacol; 2022; 13():979403. PubMed ID: 36386202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid treatment for the symptoms of autism spectrum disorder.
    Aran A; Cayam Rand D
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.
    Pretzsch CM; Freyberg J; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
    Neuropsychopharmacology; 2019 Jul; 44(8):1398-1405. PubMed ID: 30758329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
    Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD).
    Pretzsch CM; Voinescu B; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Williams S; Murphy DG; Daly E; McAlonan GM
    J Psychopharmacol; 2019 Sep; 33(9):1141-1148. PubMed ID: 31237191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
    Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terpenes and Cannabinoids Yields and Profile from Direct-Seeded and Transplanted CBD-
    Zheljazkov VD; Noller JS; Maggi F; Dale R
    J Agric Food Chem; 2022 Aug; 70(34):10417-10428. PubMed ID: 35436102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.
    Holdman R; Vigil D; Robinson K; Shah P; Contreras AE
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):451-463. PubMed ID: 34432543
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations.
    Pavlovic R; Nenna G; Calvi L; Panseri S; Borgonovo G; Giupponi L; Cannazza G; Giorgi A
    Molecules; 2018 May; 23(5):. PubMed ID: 29783790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management.
    Mazza JAS; Ferreira LS; Martins-Vieira AF; Beserra DDL; Rodrigues VA; Malcher-Lopes R; Caixeta FV
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety.
    Stolar O; Hazan A; Vissoker RE; Kishk IA; Barchel D; Lezinger M; Dagan A; Treves N; Meiri D; Berkovitch M; Kohn E; Heyman E
    Front Pharmacol; 2022; 13():977484. PubMed ID: 36249785
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study.
    Ma L; Platnick S; Platnick H
    Cureus; 2022 Aug; 14(8):e28442. PubMed ID: 36176817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects.
    Martinez Naya N; Kelly J; Corna G; Golino M; Polizio AH; Abbate A; Toldo S; Mezzaroma E
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits.
    Montagner PSS; Medeiros W; da Silva LCR; Borges CN; Brasil-Neto J; de Deus Silva Barbosa V; Caixeta FV; Malcher-Lopes R
    Front Psychiatry; 2023; 14():1210155. PubMed ID: 37671290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol and substance use disorder: Dream or reality.
    Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
    Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.